Study highlights racial and ethnic disparities in disability among older adults

Patients with no family history of colorectal cancer (CRC) whose first colonoscopy was negative may be able to delay their next screening for 15 years

Boehringer Ingelheim’s candidate stands out from other GLP-1 drugs in that it also targets the hormone glucagon. Image credit: Shutterstock/Michael Vi. Boehringer Ingelheim could soon